Закрытое акционерное общество "ФармФирма "Сотекс" (RU)
发明人:
申请号：
RU2015108664/15
公开号：
RU2015108664A
申请日:
2015.03.12
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A pharmaceutical composition in the form of a solution for intravenous and intramuscular administration containing as active ingredient 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid in a pharmacologically effective dose, as well as auxiliary veschestva.2. A pharmaceutical composition according to Claim. 1 comprising 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid at a dose of 50-300 mg.3. A pharmaceutical composition according to claim. 2 comprising 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid at a dose of 50 or 100 or 200 mg.4. A pharmaceutical composition according to Claim. 1, comprising as excipients solvent and, if necessary, a stabilizer and / or equalizer pH.5. A pharmaceutical composition according to claim. 4, comprising as water inektsiy.6 solvent. A pharmaceutical composition according to claim. 4, comprising as stabilizer the sodium metabisulfit.7. A pharmaceutical composition according to claim. 4, comprising as pH corrector 1M hydrochloric acid or 1M sodium gidroksida.8 solution. A pharmaceutical composition according to claim. 7 comprising 1M hydrochloric acid or 1M sodium hydroxide solution in an amount necessary to achieve and maintain a pH value of 3.5 to 4,5.9. Pharmaceutical composition in form of a solution for intravenous and intramuscular administration comprising 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid as active ingredient and excipients, including water for injection, sodium metabisulfite, 1M hydrochloric acid or 1M sodium hydroxide solution, with the following component ratio, wt.%: 6-methyl-2-fl1. Фармацевтическая композиция в форме раствора для внутривенного и внутримышечного введения, содержащая в качестве активного компонента 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты в фармакологически эффективной дозе, а также вспомогательные вещества.2. Фармацевтическая композиция по п. 1, содержащая 6-
